Detection of Chlamydia Pneumoniae on Cytospin Preparations from Bronchoalveolar Lavage in COPD Patients and in Lung Tissue from Advanced Emphysema

Overview

Journal Int J Chron Obstruct Pulmon Dis

Publisher Dove Medical Press

Specialty Pulmonary Medicine

Date 2008 Feb 14

PMID 18268939

Citations 6

Authors

Eva Branden

Judy Gnarpe

Gunnar Hillerdal

Lotta Orre

C Magnus Skold

Magnus Lofdahl

Hirsh Koyi

Goran Tornling

Affiliations

Soon will be listed here.

Abstract

Chronic obstructive pulmonary disease (COPD) is associated with smoking but other etiological factors contribute. Chlamydia pneumoniae is an obligate intracellular bacterium causing both acute and chronic respiratory tract infections. Studies have revealed an association between chronic C. pneumoniae infection and COPD, asthma and lung cancer but there have been difficulties detecting C. pneumoniae in the bronchial tree. Cytospin slides prepared from bronchoalveolar lavage (BAL) fluid from 14 patients with COPD, 10 healthy smokers (S) and 7 non smokers (NS) were analyzed with a fluorescein isothiocyanate labeled monoclonal antibody to C. pneumoniae. Lung tissue from 24 patients with advanced emphysema who had undergone lung volume reduction surgery (LVRS) was examined with immunohistochemistry for C. pneumoniae. Archived serum samples for detection of specific C. pneumoniae antibodies by microimmunofluorescence were available for 30 of the BAL subjects and 11 of LVRS patients. C. pneumoniae elementary body like structures were found in 29% of cytospin specimens from COPD patients, 14% of NS and 10% of HS. C. pneumoniae was detected in lung tissue in 8%. COPD patients had higher titres of IgG and IgA than NS and S. There was no association between occurrence of C. pneumoniae in BAL fluid and antibody titres. In conclusion, the assays used for detection of C. pneumoniae in lung tissue are feasible, and could be adapted in adequately powered studies to further confirm an association between C. pneumoniae infection and COPD.

Citing Articles

Molecular Mechanisms Contributing Bacterial Infections to the Incidence of Various Types of Cancer.

Sheweita S, Alsamghan A Mediators Inflamm. 2020; 2020:4070419.

PMID: 32724295 PMC: 7366195. DOI: 10.1155/2020/4070419.

Inhibitors of Apoptosis Protein Antagonists (Smac Mimetic Compounds) Control Polarization of Macrophages during Microbial Challenge and Sterile Inflammatory Responses.

Nadella V, Mohanty A, Sharma L, Yellaboina S, Mollenkopf H, Mazumdar V Front Immunol. 2018; 8:1792.

PMID: 29375545 PMC: 5767188. DOI: 10.3389/fimmu.2017.01792.

Interactions of antisera to different Chlamydia and Chlamydophila species with the ribosomal protein RPS27a correlate with impaired protein synthesis in a human choroid plexus papilloma cell line.

Almamy A, Schwerk C, Schroten H, Ishikawa H, Asif A, Reuss B Immunol Res. 2017; 65(6):1110-1123.

PMID: 28913776 DOI: 10.1007/s12026-017-8952-9.

Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts.

Asquith K, Horvat J, Kaiko G, Carey A, Beagley K, Hansbro P PLoS Pathog. 2011; 7(5):e1001339.

PMID: 21573182 PMC: 3088704. DOI: 10.1371/journal.ppat.1001339.

Isolation of Chlamydia pneumoniae from serum samples of the patients with acute coronary syndrome.

Petyaev I, Zigangirova N, Petyaev A, Pashko U, Didenko L, Morgunova E Int J Med Sci. 2010; 7(4):181-90.

PMID: 20596362 PMC: 2894221. DOI: 10.7150/ijms.7.181.

References

von Hertzen L, Alakarppa H, Koskinen R, Liippo K, Surcel H, Leinonen M . Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect. 1997; 118(2):155-64. PMC: 2808789. DOI: 10.1017/s095026889600725x. View

Michaud C, Murray C, Bloom B . Burden of disease--implications for future research. JAMA. 2001; 285(5):535-9. DOI: 10.1001/jama.285.5.535. View

Smieja M, Leigh R, Petrich A, Chong S, Kamada D, Hargreave F . Smoking, season, and detection of Chlamydia pneumoniae DNA in clinically stable COPD patients. BMC Infect Dis. 2002; 2:12. PMC: 117240. DOI: 10.1186/1471-2334-2-12. View

Theegarten D, Anhenn O, Hotzel H, Wagner M, Marra A, Stamatis G . A comparative ultrastructural and molecular biological study on Chlamydia psittaci infection in alpha-1 antitrypsin deficiency and non-alpha-1 antitrypsin deficiency emphysema versus lung tissue of patients with hamartochondroma. BMC Infect Dis. 2004; 4:38. PMC: 521078. DOI: 10.1186/1471-2334-4-38. View

Branden E, Koyi H, Gnarpe J, Gnarpe H, Tornling G . Chronic Chlamydia pneumoniae infection is a risk factor for the development of COPD. Respir Med. 2005; 99(1):20-6. DOI: 10.1016/j.rmed.2004.04.014. View

Rupp J, Droemann D, Goldmann T, Zabel P, Solbach W, Vollmer E . Alveolar epithelial cells type II are major target cells for C. pneumoniae in chronic but not in acute respiratory infection. FEMS Immunol Med Microbiol. 2004; 41(3):197-203. DOI: 10.1016/j.femsim.2004.03.004. View

Muhlestein J, Hammond E, Carlquist J, Radicke E, Thomson M, Karagounis L . Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol. 1996; 27(7):1555-61. DOI: 10.1016/0735-1097(96)00055-1. View

von Hertzen L, Isoaho R, Leinonen M, Koskinen R, Laippala P, Toyryla M . Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease. Int J Epidemiol. 1996; 25(3):658-64. DOI: 10.1093/ije/25.3.658. View

Kurashima K, Kanauchi T, Takayanagi N, Sato N, Tokunaga D, Ubukata M . Serum IgG and IgA antibodies to Chlamydia pneumoniae and severity of emphysema. Respirology. 2005; 10(5):572-8. DOI: 10.1111/j.1440-1843.2005.00752.x. View

10.

Lopez A, Murray C . The global burden of disease, 1990-2020. Nat Med. 1998; 4(11):1241-3. DOI: 10.1038/3218. View

11.

Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman M, Manninen V . Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med. 1992; 116(4):273-8. DOI: 10.7326/0003-4819-116-4-273. View

12.

Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A . Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J. 1999; 14(5):1015-22. DOI: 10.1183/09031936.99.14510159. View

13.

. Standardized lung function testing. Report working party. Bull Eur Physiopathol Respir. 1983; 19 Suppl 5:1-95. View

14.

Koyi H, Branden E, Gnarpe J, Gnarpe H, Steen B . An association between chronic infection with Chlamydia pneumoniae and lung cancer. A prospective 2-year study. APMIS. 2002; 109(9):572-80. DOI: 10.1034/j.1600-0463.2001.d01-177.x. View

15.

Kocazeybek B . Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: a case-control study. J Med Microbiol. 2003; 52(Pt 8):721-726. DOI: 10.1099/jmm.0.04845-0. View

16.

Wu L, Skinner S, Lambie N, Vuletic J, Blasi F, Black P . Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000; 162(3 Pt 1):1148-51. DOI: 10.1164/ajrccm.162.3.9912134. View

17.

Campbell L, Kuo C, GRAYSTON J . Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis. 1998; 4(4):571-9. PMC: 2640250. DOI: 10.3201/eid0404.980407. View

18.

Kuo C, Campbell L . Detection of Chlamydia pneumoniae in arterial tissues. J Infect Dis. 2000; 181 Suppl 3:S432-6. DOI: 10.1086/315615. View

19.

Laurila A, Anttila T, Laara E, Bloigu A, Virtamo J, Albanes D . Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int J Cancer. 1997; 74(1):31-4. DOI: 10.1002/(sici)1097-0215(19970220)74:1<31::aid-ijc6>3.0.co;2-1. View

20.

Saikku P, Leinonen M, Mattila K, Ekman M, Nieminen M, Makela P . Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988; 2(8618):983-6. DOI: 10.1016/s0140-6736(88)90741-6. View